Recommendations on post-trial responsibility in implantable neural device research: a multidisciplinary consensus...

Area of Science:

• Neuroscience and Medical Ethics
• Biomedical Engineering and Clinical Research

Background:

• Clinical development of implantable neural devices presents ethical challenges regarding post-trial participant responsibilities.
• Continued support for participants using investigational devices requires significant resources, expertise, and infrastructure.
• Access to ongoing care may be jeopardized by trial outcomes, financial viability, or safety concerns.

Purpose of the Study:

• To develop specific ethical guidance for post-trial responsibility in implantable neural device research.
• To address the challenge of ensuring continued support for participants within the Australian innovation context.

Main Methods:

• A modified Delphi study was conducted with a multidisciplinary panel of 24 experts.
• The panel included representatives from industry, bioethics, law, clinical specialties, engineering, regulation, and patient advocacy.
• The process involved workshops and a survey, utilizing modified RAND/UCLA methods.

Main Results:

• The expert panel developed 11 consensus recommendations for responsible post-trial practices.
• All recommendations achieved high levels of agreement and were rated as highly important.
• These are the first jurisdiction-specific recommendations for implantable neural device research in Australia.

Conclusions:

• The developed recommendations provide crucial ethical and practical standards for post-trial responsibility.
• These guidelines are anticipated to enhance ethical and practical standards in Australia and internationally.
• Urgent ethical guidance is necessary to manage the complexities of post-trial care for neural device participants.